Aglaia Therapeutics, a biotechnology startup developing new therapies that can overcome resistance to current targeted therapies in cancer patients, has completed a EUR4 million (USD4.7 million) seed funding round. Advent France Biotechnology (AFB) led the round, with the participation of Crédit Mutuel Innovation and Pierre Fabre. AFB also acted as
Welsh, Carson, Anderson & Stowe (WCAS), a private equity firm focused exclusively on the healthcare and technology industries, has acquired Argos Health, a provider of complex claims revenue cycle services to some of the country’s leading health systems.
Underdog Pharmaceuticals, a key investment of Michael Greve’s rejuvenation biotech VC Kizoo, has closed a USD10 million round of capital. Kizoo led the company’s Series Seed II round, which saw participation from both existing and new investors. Accounting for up to 40 per cent of deaths in Europe and the
21 Invest France has acquired a majority stake in Edukea group alongside Christophe Caporossi, Chairman of the group. Edukea is a training platform made up of three schools: ESO – a pioneer school for osteopathy training in France, founded in 1991; IFOA – a school dedicated to animal osteopathy, acquired
Walgreens Boots Alliance (WBA), through its wholly-owned subsidiary, Walgreen Co, is making a majority investment in Shields Health Solutions, a specialist in integrated, health system-owned specialty pharmacy care. WBA’s investment signifies another step the company is taking to accelerate innovative healthcare models for future growth, providing a platform to further
eVisit, a Virtual Care platform for large healthcare providers, has closed a USD45 million Series B financing round led by the Growth Equity business within Goldman Sachs Asset Management (Goldman Sachs), with participation from Texas Health Resources, Tom Burton and Steve Barlow (Co-founders of Health Catalyst), and existing insiders. eVisit
Leading healthcare investors Avista Capital Partners (Avista Capital) and Nordic Capital are to o sell Acino, a Swiss pharmaceutical company headquartered in Zurich, to ADQ, one of the region’s largest holding companies with a broad portfolio of major enterprises spanning key sectors of Abu Dhabi’s diversified economy. In partnership, Avista
Vision Innovation Partners, a leading eye care platform backed by Centre Partners, has acquired Ophthalmic Associates, a provider of integrated eye care services with five locations in Western Pennsylvania. The acquisition adds to Vision Innovation Partners’ significant presence in Pennsylvania and further strengthens its growing network of ophthalmology practices and
Sagewind Capital (Sagewind), a New York-based private equity firm, has invested in Federal Advisory Partners, a strategy consulting firm serving public and private sector organisations, and the federal healthcare market. Financial terms of the transaction have not been disclosed. Headquartered in Arlington, Virginia, Federal Advisory Partners has deep experience
Biotech company Anjarium Biosciences (Anjarium) has closed a CHF55.5 million (USD61 million) Series A financing, co-led by Abingworth and Gimv, with significant participation from Omega Funds, Pfizer Ventures and Surveyor Capital (a Citadel company). Anjarium’s innovative approach leverages breakthrough science and expertise at the interface of genetic medicine, synthetic biology
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
